BEGGIATO, SARAH
 Distribuzione geografica
Continente #
NA - Nord America 991
EU - Europa 461
AS - Asia 175
SA - Sud America 2
OC - Oceania 1
Totale 1.630
Nazione #
US - Stati Uniti d'America 987
IE - Irlanda 172
SG - Singapore 109
SE - Svezia 96
IT - Italia 93
VN - Vietnam 38
RU - Federazione Russa 30
DE - Germania 20
CN - Cina 14
BE - Belgio 9
CZ - Repubblica Ceca 8
UA - Ucraina 8
GB - Regno Unito 7
HK - Hong Kong 5
CA - Canada 4
JP - Giappone 3
AM - Armenia 2
AT - Austria 2
ES - Italia 2
FI - Finlandia 2
HR - Croazia 2
IN - India 2
LT - Lituania 2
BO - Bolivia 1
BT - Bhutan 1
CL - Cile 1
FR - Francia 1
HU - Ungheria 1
LU - Lussemburgo 1
NL - Olanda 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
PT - Portogallo 1
RS - Serbia 1
TR - Turchia 1
Totale 1.630
Città #
Chandler 279
Dublin 171
Singapore 89
Princeton 78
Jacksonville 63
Ashburn 55
Altamura 39
Dong Ket 38
Wilmington 29
Santa Clara 26
Los Angeles 19
Ann Arbor 15
Seattle 15
Washington 11
Chieti 10
Brussels 9
Norwalk 9
Brno 8
Munich 7
New York 7
Falls Church 6
Cagliari 3
Edinburgh 3
Redmond 3
Andover 2
Bari 2
Belleville 2
Fano 2
Frankfurt am Main 2
Lanciano 2
Milan 2
Montreal 2
Reutlingen 2
Shanghai 2
Stockholm 2
Termoli 2
Tokyo 2
Vienna 2
Yerevan 2
Zagreb 2
Šiauliai 2
Amsterdam 1
Ascoli Piceno 1
Belgrade 1
Birmingham 1
Bologna 1
Budapest 1
Cambridge 1
Chatsworth 1
Chicago 1
Cincinnati 1
Cochabamba 1
Ferrara di Monte Baldo 1
Foshan 1
Gateshead 1
Hanover 1
Istanbul 1
Jinan 1
Kuopio 1
Kyiv 1
La Mancha 1
Lappeenranta 1
Lisbon 1
London 1
Luxembourg 1
Madrid 1
Mountain View 1
Nanjing 1
New Delhi 1
Nizhniy Novgorod 1
Orlando 1
Oslo 1
Paris 1
Perm 1
Pescara 1
Phoenix 1
Pune 1
Redwood City 1
Romola 1
Shijiazhuang 1
Taiyuan 1
Thimphu 1
Tianjin 1
Verona 1
Warsaw 1
Woodbridge 1
Xingtai 1
Totale 1.072
Nome #
CDKL5 knockout leads to altered inhibitory transmission in the cerebellum of adult mice 62
Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH-018-Br impair Novel Object Recognition in mice: Behavioral, electrophysiological and neurochemical evidence 60
GET73 prevents ethanol-induced neurotoxicity in primary cultures of rat hippocampal neurons 58
Striatal adenosine-cannabinoid receptor interactions in rats over-expressing adenosine A2A receptors 57
Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles 57
Indomethacin co-crystals and their parent mixtures: Does the intestinal barrier recognize them differently? 56
Palmitoylethanolamide (PEA) as a potential therapeutic agent in Alzheimer’s disease 53
Brain dopamine transmission in health and Parkinson's disease: Modulation of synaptic transmission and plasticity through volume transmission and dopamine heteroreceptors 53
Chronic Oral Palmitoylethanolamide Administration Rescues Cognitive Deficit and Reduces Neuroinflammation, Oxidative Stress, and Glutamate Levels in A Transgenic Murine Model of Alzheimer's Disease 52
Maternal genotype determines kynurenic acid levels in the fetal brain: Implications for the pathophysiology of schizophrenia 51
Palmitoylethanolamide Blunts Amyloid-βivation and Improves Neuronal Survival in Primary Mouse Cortical Astrocyte-Neuron Co-Cultures 49
Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study 49
Geraniol pharmacokinetics, bioavailability and its multiple effects on the liver antioxidant and xenobiotic-metabolizing enzymes 49
Prenatal Dynamics of Kynurenine Pathway Metabolism in Mice: Focus on Kynurenic Acid 47
Nasal administration of nanoencapsulated geraniol/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease 46
Multiple Adenosine-Dopamine (A2A-D2 Like) Heteroreceptor Complexes in the Brain and Their Role in Schizophrenia 45
Assessment of Prenatal Kynurenine Metabolism Using Tissue Slices: Focus on the Neosynthesis of Kynurenic Acid in Mice 45
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery 44
Adenosine and Kynurenic Acid Interactions: Possible Relevance for Schizophrenia Treatment? 44
Cocaine modulates allosteric D2-σ1 receptor-receptor interactions on dopamine and glutamate nerve terminals from rat striatum 43
Functional role of striatal A2A, D2, and mGlu5 receptor interactions in regulating striatopallidal GABA neuronal transmission 43
Unfolding New Roles for Guanine-Based Purines and Their Metabolizing Enzymes in Cancer and Aging Disorders 42
Differential effects of palmitoylethanolamide against amyloid-β induced toxicity in cortical neuronal and astrocytic primary cultures from wild-type and 3xTg-AD mice 41
Astrocytic Mechanisms Involving Kynurenic Acid Control Δ 9 -Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas 41
Long-lasting alterations of hippocampal GABAergic neurotransmission in adult rats following perinatal Δ9-THC exposure 40
Improved Functional Recovery in Rat Spinal Cord Injury Induced by a Drug Combination Administered with an Implantable Polymeric Delivery System 40
The dual role of glutamatergic neurotransmission in Alzheimer’s disease: From pathophysiology to pharmacotherapy 39
Acute cocaine treatment enhances the antagonistic allosteric adenosine A2A-dopamine D2 receptor–receptor interactions in rat dorsal striatum without increasing significantly extracellular dopamine levels 39
Uptake in the central nervous system of geraniol oil encapsulated in chitosan oleate following nasal and oral administration 38
Neurotensin: A role in substance use disorder? 38
Kynurenine pathway is altered in BDNF Val66Met knock-in mice: Effect of physical exercise 37
Acute Cocaine Enhances Dopamine D2R Recognition and Signaling and Counteracts D2R Internalization in Sigma1R-D2R Heteroreceptor Complexes 37
In vitro functional characterization of GET73 as possible negative allosteric modulator of metabotropic glutamate receptor 5 36
Alterations in rat prefrontal cortex kynurenic acid levels are involved in the enduring cognitive dysfunctions induced by tetrahydrocannabinol exposure during the adolescence 32
Prenatal THC exposure raises kynurenic acid levels in the prefrontal cortex of adult rats 32
The Balance of MU-Opioid, Dopamine D2 and Adenosine A2A Heteroreceptor Complexes in the Ventral Striatal-Pallidal GABA Antireward Neurons May Have a Significant Role in Morphine and Cocaine Use Disorders 32
Astrocytic palmitoylethanolamide pre-exposure exerts neuroprotective effects in astrocyte-neuron co-cultures from a triple transgenic mouse model of Alzheimer's disease 31
Pros and Cons of Pharmacological Manipulation of cGMP-PDEs in the Prevention and Treatment of Breast Cancer 28
COR758, a negative allosteric modulator of GABA B receptors 27
Nasal biocompatible powder of Geraniol oil complexed with cyclodextrins for neurodegenerative diseases: physicochemical characterization and in vivo evidences of nose to brain delivery 22
Time of Day-Dependent Alterations in Hippocampal Kynurenic Acid, Glutamate, and GABA in Adult Rats Exposed to Elevated Kynurenic Acid During Neurodevelopment 19
Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's Disease 17
Totale 1.771
Categoria #
all - tutte 9.710
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.710


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021276 50 34 41 19 23 34 5 1 4 2 1 62
2021/2022222 5 0 2 38 5 3 15 11 16 5 22 100
2022/2023746 81 126 41 80 49 121 39 68 85 10 31 15
2023/2024273 24 10 18 10 13 80 68 11 5 10 8 16
2024/2025254 59 119 50 14 12 0 0 0 0 0 0 0
Totale 1.771